Can-Fite BioPharma Ltd. Sponsored ADR
(NYSE Amex Equities : CANF)

( )
CANF After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
CELGCelgene Corporation
-0.63%104.501.1%$1236.73m
GILDGilead Sciences, Inc.
-0.50%72.460.9%$611.09m
AMGNAmgen Inc.
0.09%170.121.1%$450.74m
REGNRegeneron Pharmaceuticals, Inc.
-0.69%384.852.7%$340.98m
BIIBBiogen Inc.
-0.27%308.971.2%$326.02m
ALXNAlexion Pharmaceuticals, Inc.
0.94%108.611.9%$253.52m
VRTXVertex Pharmaceuticals Incorporated
-0.33%146.551.9%$219.58m
ALNYAlnylam Pharmaceuticals, Inc
0.39%132.8510.0%$193.95m
NKTRNektar Therapeutics
5.71%52.596.1%$190.49m
INCYIncyte Corporation
-0.22%98.782.5%$170.92m
JUNOJuno Therapeutics, Inc.
4.18%62.8513.5%$144.30m
AAgilent Technologies, Inc.
0.98%69.361.5%$130.11m
ILMNIllumina, Inc.
-0.23%214.863.5%$125.36m
BLUEBluebird Bio, Inc.
0.36%167.8017.2%$111.62m
EXASExact Sciences Corporation
0.17%59.2726.0%$109.26m

Company Profile

Can-Fite BioPharma Ltd. operates as a clinical-stage biopharmaceutical company, which focuses on developing orally bioavailable small molecule therapeutic products for the treatment of autoimmune-inflammatory, oncological and ophthalmic diseases. Its products include pipeline drugs such as CF101, CF102 and CF602. The company offers drugs for the treatment of Psoriasis, Rheumatic Arthritis, Glaucoma, Uveitis, Crohn's disease, Osteoathritis, Hepatitis C, and Liver Cancer. Can-Fite BioPharma was founded by Pnina Fishman and Ilan Cohn on September 11, 1994 and is headquartered in Petach Tikva, Israel.